
-
Past Deadline: Feb 13, 2022
Epoch Foundation's Startup Global Program based in Taipei, Taiwan: May 16-27
otherEpoch Foundation of Taipei Taiwan has invited MIT-connected startups to apply to their Global Startup Program. A number of MIT startups have participated in this program and found it very productive.
-
nuTonomy
Emilio Frazzoli, MIT Professor of Aeronautics & Astronautics, nuTonomy CTO
-
Sourcemap Inc.
New York, NYSourcemap is a fast-paced startup delivering the first software-as-a-service for supply chain mapping so that companies can account for and optimize the performance of their end-to-end supply chain. Sourcemap has fifteen major clients including internationally-known brands in a number of sectors:... More -
Past Deadline: Mar 14, 2019
Global Automotive Leader seeks AI and 3D Printing Startups
meetingA $17B/year global leader in automotive technologies, Faurecia is anticipating all the challenges of a changing industry. With the help of strategic partnerships with companies, start-ups and academia within an open innovation ecosystem, Faurecia technologies address two key aspects of mobility: the Cockpit of the Future for a safer, more comfortable, and more intuitive experience in the cockpit of the future, and Sustainable Mobility for cleaner and more environmentally-friendly transportation around the world. Owns more than 300 assembly lines in the US.
-
iQ3Connect
Ali Merchant, President and CEO, iQ3Connect
-
Sports, Nutrition & Wellness - Lightning Talks
- Simon Hong, Founder & CEO, Robilis
- Iris Sherman, Co-Founder & President, Kitchology
- Laila Zemrani, Co-Founder & CEO, Fitnescity
- Fredric D. Abramson, Founder & CEO, Digital Nutrition
- Nan-Wei Gong, Co-Founder & CEO, figur8
- Alessandro Babini, Co-Founder, Humon
- Josh Sarmir, Co-Founder & CEO, SplitSage
- Bob Jones, Founder & CEO, Food for Sleep
-
Robotics Workshop 2017 - Introductory Remarks - Trond Undheim
Robotics Welcome
-
Past Deadline: Aug 4, 2024
Speak at 2024 MITEI annual research conference
speakerThis year’s theme will be built around ensuring the durability of the energy transition in the face of future unknowns.
- Tue, September 10, 2019 | Workshop
MIT Startup Exchange Workshop: Real world IoT & edge computing
MIT CampusMIT Startup Exchange presents its September Startup Workshop, centered around real-world IoT and edge computing. Many companies are grappling with how to use IoT and data/AI in their organization to monitor, predict, improve, and transform what they do. Meanwhile, many MIT startups are developing and providing innovative technology solutions to answer these very questions for industry. This workshop will present perspectives from industry leaders, academics, and corporate investors, while also showcasing select MIT startups in the field.
-
AI Driven Bloodless Blood Tests: GPx
AI Driven Bloodless Blood Tests
Sean (Shunsuke) Matsuoka, Co-Founder & COO, GPx
GPx: https://gpx.ai/In an aging society, the number of heart failure patients is increasing, making the prevention of readmissions and reduction of medical costs critical issues. Remote monitoring using invasive implantable devices has proven effective in reducing heart failure readmissions, but its use remains limited.
To address this, GPx has developed an algorithm that non-invasively predicts signs of heart failure exacerbation. This algorithm was created using clinical trial data from monitoring 245 heart failure patients over 6 months to a year at eight facilities, including the Mayo Clinic in the U.S. The algorithm links digital
biomarker data with vital blood tests (NT-proBNP and creatinine) to achieve high-precision prediction and early medical intervention.Additionally, with a grant of 1.2 billion yen provided through AMED, we are collaborating with the National Cerebral and Cardiovascular Center (Dr. Chisato Izumi) to conduct a clinical trial involving 400 patients starting April 2025. The trial will be conducted at the National Cerebral and Cardiovascular Center, Kyoto University, Kobe University, and Kochi University.
Furthermore, at this year's MIT Japan Conference, we will unveil a groundbreaking point-of-care (POC) potassium testing device for the first time. At the conference, we aim to explore the feasibility of applying our technology to other conditions (such as kidney failure, pulmonary arterial hypertension, and cardio-oncology) and to assess the potential for providing algorithm-based services for heart failure patients within Japan.